Stanozolol Inj 50mg Ice Pharmaceuticals

£55.00

Stanozolol Inj 50mg Ice Pharmaceuticals represents a synthetic anabolic steroid compound available for advanced laboratory research applications. This injectable formulation enables precise analytical studies of stanozolol’s molecular interactions and biochemical properties in controlled research environments.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Guaranteed Safe Checkout

Stanozolol Inj 50mg Ice Pharmaceuticals
Stanozolol Inj 50mg Ice Pharmaceuticals
£55.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Stanozolol Inj at a Glance

Stanozolol Inj 50mg Ice Pharmaceuticals is a synthetic anabolic androgenic steroid compound derived from dihydrotestosterone, specifically designed for comprehensive laboratory research applications. This injectable formulation provides researchers at Stroid UK Shop with a standardised platform to investigate stanozolol’s molecular mechanisms, receptor binding affinities, and biochemical interactions within controlled experimental frameworks. The compound’s unique structural modifications distinguish it from other anabolic steroids, making it valuable for comparative studies examining androgenic versus anabolic properties. Research institutions utilise this preparation to analyse protein synthesis pathways, nitrogen retention mechanisms, and cellular metabolic responses under laboratory conditions.

Laboratory Applications

Scientific investigations involving stanozolol focus on examining its molecular interactions with androgen receptors, studying its effects on collagen synthesis, and evaluating its impact on various enzymatic pathways. Researchers frequently examine this compound alongside selective androgen receptor modulators to compare receptor selectivity profiles and tissue-specific responses. Laboratory studies investigate stanozolol’s influence on hepatic function markers, lipid metabolism parameters, and cardiovascular risk biomarkers. Additional research applications include analysing its interaction with other compounds found in peptide research collections and examining synergistic effects in combination studies. The injectable formulation allows for precise dosimetric control in pharmacokinetic studies, enabling researchers to establish accurate concentration-response relationships and metabolic clearance rates.

Technical Specifications

Stanozolol Injection Research Specifications
Parameter Specification
Active Compound Stanozolol
Concentration 50mg/ml
Formulation Injectable solution
Manufacturer Ice Pharmaceuticals
CAS Number 10418-03-8
Molecular Formula C21H32N2O
Storage Requirements Room temperature, protected from light

This formulation provides consistent results for researchers examining stanozolol compounds in various experimental protocols, ensuring reproducible data across multiple laboratory sessions.

Research Compliance

This stanozolol injection is manufactured exclusively for in-vitro research purposes and is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure proper handling procedures, appropriate safety protocols, and compliance with institutional research guidelines when conducting studies involving this compound.

Related